Lopinavir And Ritonavir Tablets IP Trade Information
Minimum Order Quantity
100 Packs
Supply Ability
5000 Packs Per Month
Delivery Time
7 Days
Main Domestic Market
All India
About Lopinavir And Ritonavir Tablets IP
Lopinavir and Ritonavir Tablets IP are a combination of two antiviral medications used for the treatment of HIV infection. These tablets come in a dosage form of 30 and are of medicine grade. They are suitable for use in hospitals and other medical facilities. The tablets should be stored in a dry place to maintain their efficacy. These tablets work by inhibiting the activity of the HIV protease enzyme, which is essential for the virus to replicate and spread. This medication helps to reduce the amount of virus in the body and can also improve the immune systems function. Lopinavir and Ritonavir Tablets IP are an effective treatment for HIV infection and can help to improve the quality of life of those living with the virus.
FAQs of Lopinavir And Ritonavir Tablets IP:
Q: What are Lopinavir and Ritonavir Tablets IP used for?
A: Lopinavir and Ritonavir Tablets IP are used for the treatment of HIV infection.
Q: What is the dosage form of these tablets?
A: Lopinavir and Ritonavir Tablets IP come in a dosage form of 30 tablets.
Q: What is the storage requirement for these tablets?
A: These tablets should be stored in a dry place to maintain their efficacy.
Q: Are these tablets suitable for use in hospitals?
A: Yes, these tablets are suitable for use in hospitals and other medical facilities.
Q: How do Lopinavir and Ritonavir Tablets IP work?
A: These tablets work by inhibiting the activity of the HIV protease enzyme, which is essential for the virus to replicate and spread.
Tell us about your requirement
Price:
Quantity
Select Unit
50
100
200
250
500
1000+
Additional detail
Mobile number
Email
Name
Comapny Name
Phone Number
Email Id
City / State
Confirm Your Requirement
Verification Code
Did not receive yet?
Resend OTP
You’re Done!
We have received your requirements and will reply shortly with the best price.